Effect of Extracorporeal Membrane Oxygenation Use on Sedative Requirements in Patients with Severe Acute Respiratory Distress Syndrome

scientific article

Effect of Extracorporeal Membrane Oxygenation Use on Sedative Requirements in Patients with Severe Acute Respiratory Distress Syndrome is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1002/PHAR.1760
P8608Fatcat IDrelease_akaiitosijaj3ctw4fc45s5f4q
P698PubMed publication ID27130442

P50authorDaniel BrodieQ87827918
Matthew D. BacchettaQ91549093
P2093author name stringRobin Ruthazer
John W Devlin
Amy L Dzierba
Caroline Der Nigoghossian
Justin Muir
Greg Schumaker
Russel Roberts
Joshua Etheridge
P2860cites workAPACHE II: a severity of disease classification systemQ29547729
Extracorporeal Membrane Oxygenation for 2009 Influenza A(H1N1) Acute Respiratory Distress Syndrome.Q30381573
Sedation and analgesia usage in severe pandemic H1N1 (2009) infection: a comparison to respiratory failure secondary to other infectious pneumoniasQ30410665
Association between tidal volume size, duration of ventilation, and sedation needs in patients without acute respiratory distress syndrome: an individual patient data meta-analysis.Q30817425
Neuromuscular blockers in early acute respiratory distress syndromeQ34023977
Intensive Care Delirium Screening Checklist: evaluation of a new screening toolQ34082486
Early sedation and clinical outcomes of mechanically ventilated patients: a prospective multicenter cohort studyQ34468933
Propofol infusion syndrome.Q34637170
The association between acute respiratory distress syndrome, delirium, and in-hospital mortality in intensive care unit patientsQ34987134
Efficacy and economic assessment of conventional ventilatory support versus extracorporeal membrane oxygenation for severe adult respiratory failure (CESAR): a multicentre randomised controlled trialQ35003693
Opioid conversions in acute careQ36735197
Sequestration of drugs in the circuit may lead to therapeutic failure during extracorporeal membrane oxygenationQ36928231
Review of a large clinical series: sedation and analgesia usage with airway pressure release and assist-control ventilation for acute lung injury.Q37275016
Extracorporeal membrane oxygenation for ARDS in adultsQ37956671
The pain, agitation, and delirium care bundle: synergistic benefits of implementing the 2013 Pain, Agitation, and Delirium Guidelines in an integrated and interdisciplinary fashionQ38132576
Extracorporeal life support for adults with severe acute respiratory failure.Q38185815
Dexmedetomidine vs midazolam for sedation of critically ill patients: a randomized trialQ38383872
The Richmond Agitation-Sedation Scale: validity and reliability in adult intensive care unit patientsQ39635309
Benzodiazepine side effects: role of pharmacokinetics and pharmacodynamicsQ40955466
Use of ECMO in the Management of Severe Acute Respiratory Distress Syndrome: A Survey of Academic Medical Centers in the United StatesQ41010765
Prolonged sedation due to accumulation of conjugated metabolites of midazolamQ42276898
Determinants of drug absorption in different ECMO circuits.Q42362818
Propylene glycol accumulation in critically ill patients receiving continuous intravenous lorazepam infusionsQ43240250
Monitoring sedation status over time in ICU patients: reliability and validity of the Richmond Agitation-Sedation Scale (RASS).Q44473697
Pharmacoeconomic modeling of lorazepam, midazolam, and propofol for continuous sedation in critically ill patientsQ46721363
Sedative clearance during extracorporeal membrane oxygenationQ46857795
Factors predisposing to coma and delirium: fentanyl and midazolam exposure; CYP3A5, ABCB1, and ABCG2 genetic polymorphisms; and inflammatory factors.Q48092301
Impact of a national propofol shortage on duration of mechanical ventilation at an academic medical centerQ48230012
Simultaneous modeling of the pharmacokinetic and pharmacodynamic properties of benzodiazepines. I: Lorazepam.Q50798434
In vitro evaluation of sedative drug losses during extracorporeal membrane oxygenation.Q51417979
P433issue6
P407language of work or nameEnglishQ1860
P921main subjectacute respiratory distress syndromeQ344873
sedativeQ847705
extracorporeal membrane oxygenationQ1385195
P304page(s)607-616
P577publication date2016-04-30
P1433published inPharmacotherapyQ7180800
P1476titleEffect of Extracorporeal Membrane Oxygenation Use on Sedative Requirements in Patients with Severe Acute Respiratory Distress Syndrome
P478volume36

Reverse relations

cites work (P2860)
Q39033001Evaluation of Altered Drug Pharmacokinetics in Critically Ill Adults Receiving Extracorporeal Membrane Oxygenation
Q47376514Ketamine use in sedation management in patients receiving extracorporeal membrane oxygenation
Q39023540Limiting sedation for patients with acute respiratory distress syndrome - time to wake up.
Q39188586Medicating patients during extracorporeal membrane oxygenation: the evidence is building
Q55393633Optimising drug dosing in patients receiving extracorporeal membrane oxygenation.
Q64122290The Use of Volatile Anesthetics as Sedatives for Acute Respiratory Distress Syndrome

Search more.